Stockreport

Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think [Seeking Alpha]

Travere Therapeutics, Inc.  (TVTX) 
PDF Competition in IgAN from larger players like Novartis and Vertex is intensifying, making FILSPARI's FSGS approval pivotal for the company's future growth. FILSPARI's [Read more]